Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Neuropsychologia. 2017 Feb 22;99:37–47. doi: 10.1016/j.neuropsychologia.2017.02.016

Table 1.

Demographic Data (means and standard error) for the PD patients and healthy controls.

HC (n=22) PD exp 1 (n=12) PD exp 2 (n=11)
Sample Size (N) 22 12 11
Age (years) 63.9(1.6) 59.3(2.9) 58.9(2.6)
Gender (M: F)** 12:10 8:4 6:5
Education (years) 14.5(.7) 13.7(.6) 13.7(.7)
MMSE 29.4(.2) 28.9 (.35) 28.6 (.4)
CESD 7 14.9 (2.5)
BDI-II 9.8 (1.7)
LEDD 670.9(184.9) 500.9 (127.8)
Disease Duration (years) + 11.8(1.8) 12.9 (1.7)
UPDRS dorsal 30.9 (2.8)
UPDRS ventral 30.1(3.4)
UPDRS chronic 25.0 (3.76) n=9
UPDRS acute 24.11 (3.69) n=9
UPDRS OFF 31.66 (3.99) n=9

MMSE=Mini Mental State Examination, CESD=Center for Epidemiologic Studies Depression Scale, BDI-II=Beck Depression Inventory II, UPDRS=Unified Parkinson’s Disease Rating Scale Motor, LEDD=Levodopa Daily Dosis